Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Oncology Pharmaceutical Market in China: The Year of the Crab

This article was originally published in Start Up

Executive Summary

Cancer has overtaken respiratory and infectious diseases as the leading cause of mortality in both urban and rural China, creating an enormous demand for anti-cancer pharmaceuticals. According to "China Anti-Cancer Drug Market", a report distributed by FDC-Windhover Elsevier, the sales growth of anti-cancer drugs in China spiked from 11.1% in 2006 to 25.4% in 2007, at which point the market was worth $3.5 billion.

Related Content





Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts